Microfluidic Systems for Cancer Diagnosis and Applications

AKGÖNÜLLÜ S., Bakhshpour M., ÖZDEN A. K., DENİZLİ A.

MICROMACHINES, cilt.12, sa.11, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 12 Sayı: 11
  • Basım Tarihi: 2021
  • Doi Numarası: 10.3390/mi12111349
  • Dergi Adı: MICROMACHINES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Aerospace Database, Communication Abstracts, Compendex, INSPEC, Metadex, Directory of Open Access Journals, Civil Engineering Abstracts
  • Anahtar Kelimeler: biomaterials, microfluidics, single cell analysis, cancer diagnosis, CRYSTAL MICROBALANCE BIOSENSOR, LABEL-FREE, TECHNOLOGIES, CELLS, OPPORTUNITIES, BIOMARKERS, NANOTECHNOLOGY, IMPEDANCE, PLATFORM, DEVICES
  • Bursa Uludağ Üniversitesi Adresli: Hayır

Özet

Microfluidic devices have led to novel biological advances through the improvement of micro systems that can mimic and measure. Microsystems easily handle sub-microliter volumes, obviously with guidance presumably through laminated fluid flows. Microfluidic systems have production methods that do not need expert engineering, away from a centralized laboratory, and can implement basic and point of care analysis, and this has attracted attention to their widespread dissemination and adaptation to specific biological issues. The general use of microfluidic tools in clinical settings can be seen in pregnancy tests and diabetic control, but recently microfluidic platforms have become a key novel technology for cancer diagnostics. Cancer is a heterogeneous group of diseases that needs a multimodal paradigm to diagnose, manage, and treat. Using advanced technologies can enable this, providing better diagnosis and treatment for cancer patients. Microfluidic tools have evolved as a promising tool in the field of cancer such as detection of a single cancer cell, liquid biopsy, drug screening modeling angiogenesis, and metastasis detection. This review summarizes the need for the low-abundant blood and serum cancer diagnosis with microfluidic tools and the progress that has been followed to develop integrated microfluidic platforms for this application in the last few years.